Alamar Biosciences, Inc.

ALMR

ALMRAlamar Biosciences, Inc. US flag

NASDAQ Global Select

25.15

USD

+1.23

- -

235.78MMarket Cap

Income Statement (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Sales/Revenue/Turnover	25	74
+ Sales & Services Revenue	25	74
- Cost of Revenue	17	33
+ Cost of Goods & Services	17	33
Gross Profit	9	42
+ Other Operating Income	- -	- -
- Operating Expenses	58	73
+ Selling, General & Admin	19	36
+ Research & Development	39	37
+ Other Operating Expense	- -	- -
Operating Income (Loss)	-50	-31
- Non-Operating (Income) Loss	-3	-2
+ Interest Expense, Net	-3	-2
+ Interest Expense	2	- -
- Interest Income	5	2
+ Other Non-Op (Income) Loss	- -	- -
Pretax Income	-47	-29
- Income Tax Expense (Benefit)	- -	1
- (Income) Loss from Affiliates	- -	- -
Income (Loss) from Cont Ops	-47	-30
- Net Extraordinary Losses (Gains)	- -	- -
+ Discontinued Operations	- -	- -
+ Extraord. & Accounting Changes	- -	- -
Income (Loss) Incl. MI	-47	-30
- Minority Interest	- -	- -
Net Income, GAAP	-47	-30
- Preferred Dividends	- -	- -
- Other Adjustments	- -	- -
Net Income Avail to Common, GAAP	-47	-30
EBIT	-50	-31
EBITDA	-46	-27
EBITDA Margin (%)	-184.45	-37.02
EBITA	-50	-31
Gross Margin (%)	34.23	56.2
Operating Margin (%)	-197.15	-42.22
Profit Margin (%)	-187.23	-40.18
Sales per Employee	- -	- -
Dividend per Share	- -	- -
Depreciation Expense	3	4
Basic Weighted Avg Shares	67	67
Basic EPS, GAAP	-0.71	-0.45
Basic EPS from Cont Ops	-0.71	-0.45
Diluted Weighted Avg Shares	67	67
Diluted EPS, GAAP	-0.71	-0.45
Diluted EPS from Cont Ops	-0.71	-0.45

Balance Sheet (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Total Current Assets	107	95
+ Cash, Cash Equivalents & STI	79	30
+ Cash & Cash Equivalents	27	30
+ ST Investments	53	- -
+ Accounts & Notes Receiv	7	13
+ Accounts Receivable, Net	7	13
+ Notes Receivable, Net	- -	- -
+ Loans Receivable, Net	- -	- -
+ Other Receivable, Net	1	- -
+ Inventories	14	38
+ Raw Materials	9	25
+ Work In Process	1	3
+ Finished Goods	4	11
+ Inventory Adjustments	- -	- -
+ Other Inventory	- -	- -
+ Other ST Assets	6	13
+ Misc ST Assets	- -	- -
+ Prepaid Expenses	- -	- -
+ ST Derivative & Hedging Assets	- -	- -
+ ST Assets Held-for-Sale	- -	- -
+ ST Deferred Tax Assets	- -	- -
Total Noncurrent Assets	43	45
+ Property, Plant & Equip, Net	35	37
+ Property, Plant & Equip	41	45
- Accumulated Depreciation	6	8
+ LT Investments & Receivables	- -	- -
+ LT Investments	- -	- -
+ LT Receivables	- -	- -
+ Other LT Assets	8	9
+ Total Intangible Assets	2	2
+ Goodwill	- -	- -
+ Other Intangible Assets	2	2
+ LT Deferred Tax Assets	- -	- -
+ LT Derivative & Hedging Assets	- -	- -
+ Misc LT Assets	6	7
Total Assets	150	140
+ Payables & Accruals	9	14
+ Accounts Payable	6	6
+ Accrued Taxes	- -	- -
+ Interest & Dividends Payable	- -	- -
+ Other Payables & Accruals	2	8
+ ST Debt	2	2
+ ST Borrowings	- -	- -
+ ST Finance Leases	2	2
+ Other ST Liabilities	6	8
+ Deferred Revenue	1	- -
+ Derivatives & Hedging	- -	- -
+ Deferred Tax Liabilities	- -	- -
+ Misc ST Liabilities	5	8
Total Current Liabilities	17	24
+ LT Debt	31	39
+ LT Borrowings	- -	10
+ LT Finance Leases	31	30
+ Other LT Liabilities	235	236
+ Accrued Liabilities	- -	- -
+ Pension Liabilities	- -	- -
+ Deferred Revenue	- -	- -
+ Deferred Tax Liabilities	- -	- -
+ Derivatives & Hedging	- -	- -
+ Misc LT Liabilities	235	236
Total Noncurrent Liabilities	266	275
Total Liabilities	283	299
+ Preferred Equity and Hybrid Capital	- -	- -
+ Share Capital & APIC	5	10
+ Common Stock	- -	- -
+ Additional Paid in Capital	5	10
- Treasury Stock	- -	- -
+ Retained Earnings	-139	-169
+ Other Equity	- -	- -
Equity Before Minority Interest	-133	-159
+ Minority/Non Controlling Interest	- -	- -
Total Equity	-133	-159
Total Liabilities & Equity	150	140
Shares Outstanding	67	67
Number of Employees	- -	- -
Capital Leases - Total	33	32
Net Debt	-27	-20
Net Debt to Equity	20.07	12.7
Tangible Common Equity Ratio	-91.85	-116.62
Current Ratio	6.43	3.99
Cash Conversion Cycle	- -	305.76

Cash Flow Statement (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

+ Net Income	-47	-30
+ Depreciation & Amortization	3	4
+ Non-Cash Items	1	5
+ Stock-Based Compensation	1	3
+ Deferred Income Taxes	- -	- -
+ Asset Impairment Charge	- -	- -
+ Other Non-Cash Adj	- -	2
+ Chg in Non-Cash Work Cap	-12	-33
+ (Inc) Dec in Accts Receiv	-5	-5
+ (Inc) Dec in Inventories	-9	-24
+ (Inc) Dec in Prepaid Assets	-2	-6
+ Inc (Dec) in Accts Payable	6	6
+ Inc (Dec) in Other	-2	-3
+ Net Cash From Disc Ops	- -	- -
Cash from Operating Activities	-55	-54
+ Change in Fixed & Intang	- -	- -
+ Disp in Fixed & Intang	- -	- -
+ Disp of Fixed Prod Assets	- -	- -
+ Disp of Intangible Assets	- -	- -
+ Acq of Fixed & Intang	-3	-5
+ Acq of Fixed Prod Assets	-3	-5
+ Acq of Intangible Assets	- -	- -
+ Cash (Repurchase) of Equity	1	1
+ Increase in Capital Stock	1	1
+ Decrease in Capital Stock	- -	- -
+ Net Change in LT Investment	-51	53
+ Dec in LT Investment	42	58
+ Inc in LT Investment	-93	-5
+ Net Cash From Acq & Div	- -	- -
+ Cash from Divestitures	- -	- -
+ Cash for Acq of Subs	- -	- -
+ Cash for JVs	- -	- -
+ Other Investing Activities	- -	-1
+ Net Cash From Disc Ops	- -	- -
Cash from Investing Activities	-54	46
+ Dividends Paid	- -	- -
+ Net Cash From Debt	-15	20
+ Cash From Debt	- -	20
+ Repayments of Debt	-15	- -
+ Other Financing Activities	127	-11
+ Net Cash From Disc Ops	- -	- -
Cash from Financing Activities	113	11
Effect of Foreign Exchange Rates	- -	- -
Net Changes in Cash	4	3
EBITDA	-46	-27
EBITDA Margin (%)	-184.45	-37.02
Free Cash Flow	-58	-59
Net Cash Paid for Acquisitions	- -	- -
Free Cash Flow to Firm	- -	- -
Free Cash Flow to Equity	- -	-39
Free Cash Flow per Basic Share	-0.87	-0.89
Price/Free Cash Flow	- -	- -
Cash Flow to Net Income	1.17	1.8
Capital Expenditures	-3	-5